Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain
Identifieur interne : 002A45 ( Main/Corpus ); précédent : 002A44; suivant : 002A46Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain
Auteurs : Allen D. RosesSource :
- Neurobiology of Disease [ 0969-9961 ] ; 1997.
Abstract
Age-dependent neurodegeneration in Alzheimer disease (AD) may be viewed as a complex interaction among: (i) susceptibility polymorphisms, (ii) somatic mutations or alterations that occur over extended periods of time, and (iii) environmental interactions. Putative “sporadic” diseases appear to have a much stronger genetic component than had been considered previously. For example, in Alzheimer disease, apolipoprotein E is a major susceptibility locus that accounts for approximately half the heritability. Specific APOE genotypes are associated with different relative risks and age of onset distributions. Disease may be expressed as a confluence of several genetic risk factors, superimposed upon the age-dependent increments of somatic mitochondrial mutations, and environmental determinants such as head injury, stroke, or hypoxia. A matrix involving each of these complex factors may influence the age of onset of AD in a particular individual. With careful clinically based family and epidemiological studies, it is now possible to tease out the relevant genetic contributions from the confluence of other factors leading to complex disease affecting specific sets of neurons. The highly intricate maze of contributing factors provides many potential unanticipated opportunities to design rational therapeutic and preventative strategies.
Url:
DOI: 10.1006/nbdi.1997.0161
Links to Exploration step
ISTEX:4E715B685F8A5777A4925F50E172B66A5E943551Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain</title><author><name sortKey="Roses, Allen D" sort="Roses, Allen D" uniqKey="Roses A" first="Allen D." last="Roses">Allen D. Roses</name><affiliation><mods:affiliation>Duke University Medical Center, Durham, North Carolina, 27710-2900</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4E715B685F8A5777A4925F50E172B66A5E943551</idno><date when="1997" year="1997">1997</date><idno type="doi">10.1006/nbdi.1997.0161</idno><idno type="url">https://api.istex.fr/document/4E715B685F8A5777A4925F50E172B66A5E943551/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">002A45</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain</title><author><name sortKey="Roses, Allen D" sort="Roses, Allen D" uniqKey="Roses A" first="Allen D." last="Roses">Allen D. Roses</name><affiliation><mods:affiliation>Duke University Medical Center, Durham, North Carolina, 27710-2900</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Neurobiology of Disease</title><title level="j" type="abbrev">YNBDI</title><idno type="ISSN">0969-9961</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1997">1997</date><biblScope unit="volume">4</biblScope><biblScope unit="issue">3–4</biblScope><biblScope unit="page" from="170">170</biblScope><biblScope unit="page" to="185">185</biblScope></imprint><idno type="ISSN">0969-9961</idno></series><idno type="istex">4E715B685F8A5777A4925F50E172B66A5E943551</idno><idno type="DOI">10.1006/nbdi.1997.0161</idno><idno type="PII">S0969-9961(97)90161-3</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0969-9961</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Age-dependent neurodegeneration in Alzheimer disease (AD) may be viewed as a complex interaction among: (i) susceptibility polymorphisms, (ii) somatic mutations or alterations that occur over extended periods of time, and (iii) environmental interactions. Putative “sporadic” diseases appear to have a much stronger genetic component than had been considered previously. For example, in Alzheimer disease, apolipoprotein E is a major susceptibility locus that accounts for approximately half the heritability. Specific APOE genotypes are associated with different relative risks and age of onset distributions. Disease may be expressed as a confluence of several genetic risk factors, superimposed upon the age-dependent increments of somatic mitochondrial mutations, and environmental determinants such as head injury, stroke, or hypoxia. A matrix involving each of these complex factors may influence the age of onset of AD in a particular individual. With careful clinically based family and epidemiological studies, it is now possible to tease out the relevant genetic contributions from the confluence of other factors leading to complex disease affecting specific sets of neurons. The highly intricate maze of contributing factors provides many potential unanticipated opportunities to design rational therapeutic and preventative strategies.</div></front></TEI><istex><corpusName>elsevier</corpusName><author><json:item><name>Allen D. Roses</name><affiliations><json:string>Duke University Medical Center, Durham, North Carolina, 27710-2900</json:string></affiliations></json:item></author><language><json:string>eng</json:string></language><abstract>Age-dependent neurodegeneration in Alzheimer disease (AD) may be viewed as a complex interaction among: (i) susceptibility polymorphisms, (ii) somatic mutations or alterations that occur over extended periods of time, and (iii) environmental interactions. Putative “sporadic” diseases appear to have a much stronger genetic component than had been considered previously. For example, in Alzheimer disease, apolipoprotein E is a major susceptibility locus that accounts for approximately half the heritability. Specific APOE genotypes are associated with different relative risks and age of onset distributions. Disease may be expressed as a confluence of several genetic risk factors, superimposed upon the age-dependent increments of somatic mitochondrial mutations, and environmental determinants such as head injury, stroke, or hypoxia. A matrix involving each of these complex factors may influence the age of onset of AD in a particular individual. With careful clinically based family and epidemiological studies, it is now possible to tease out the relevant genetic contributions from the confluence of other factors leading to complex disease affecting specific sets of neurons. The highly intricate maze of contributing factors provides many potential unanticipated opportunities to design rational therapeutic and preventative strategies.</abstract><qualityIndicators><score>7.232</score><pdfVersion>1.1</pdfVersion><pdfPageSize>540 x 713 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>0</keywordCount><abstractCharCount>1348</abstractCharCount><pdfWordCount>9410</pdfWordCount><pdfCharCount>60473</pdfCharCount><pdfPageCount>16</pdfPageCount><abstractWordCount>186</abstractWordCount></qualityIndicators><title>Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain</title><pii><json:string>S0969-9961(97)90161-3</json:string></pii><genre><json:string>review-article</json:string></genre><host><volume>4</volume><pii><json:string>S0969-9961(00)X0028-9</json:string></pii><pages><last>185</last><first>170</first></pages><issn><json:string>0969-9961</json:string></issn><issue>3–4</issue><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><title>Neurobiology of Disease</title><publicationDate>1997</publicationDate></host><categories><wos><json:string>CLINICAL NEUROLOGY</json:string><json:string>NEUROSCIENCES</json:string></wos></categories><publicationDate>1997</publicationDate><copyrightDate>1997</copyrightDate><doi><json:string>10.1006/nbdi.1997.0161</json:string></doi><id>4E715B685F8A5777A4925F50E172B66A5E943551</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/4E715B685F8A5777A4925F50E172B66A5E943551/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/4E715B685F8A5777A4925F50E172B66A5E943551/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/4E715B685F8A5777A4925F50E172B66A5E943551/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>ELSEVIER</publisher><availability><p>ELSEVIER</p></availability><date>1997</date></publicationStmt><notesStmt><note>R. N. RosenbergS. B. PrusinerS. DiMauroR. L. Barchi, Eds.</note><note type="content">Section title: Review</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain</title><author><persName><forename type="first">Allen D.</forename><surname>Roses</surname></persName><affiliation>Duke University Medical Center, Durham, North Carolina, 27710-2900</affiliation></author></analytic><monogr><title level="j">Neurobiology of Disease</title><title level="j" type="abbrev">YNBDI</title><idno type="pISSN">0969-9961</idno><idno type="PII">S0969-9961(00)X0028-9</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1997"></date><biblScope unit="volume">4</biblScope><biblScope unit="issue">3–4</biblScope><biblScope unit="page" from="170">170</biblScope><biblScope unit="page" to="185">185</biblScope></imprint></monogr><idno type="istex">4E715B685F8A5777A4925F50E172B66A5E943551</idno><idno type="DOI">10.1006/nbdi.1997.0161</idno><idno type="PII">S0969-9961(97)90161-3</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1997</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Age-dependent neurodegeneration in Alzheimer disease (AD) may be viewed as a complex interaction among: (i) susceptibility polymorphisms, (ii) somatic mutations or alterations that occur over extended periods of time, and (iii) environmental interactions. Putative “sporadic” diseases appear to have a much stronger genetic component than had been considered previously. For example, in Alzheimer disease, apolipoprotein E is a major susceptibility locus that accounts for approximately half the heritability. Specific APOE genotypes are associated with different relative risks and age of onset distributions. Disease may be expressed as a confluence of several genetic risk factors, superimposed upon the age-dependent increments of somatic mitochondrial mutations, and environmental determinants such as head injury, stroke, or hypoxia. A matrix involving each of these complex factors may influence the age of onset of AD in a particular individual. With careful clinically based family and epidemiological studies, it is now possible to tease out the relevant genetic contributions from the confluence of other factors leading to complex disease affecting specific sets of neurons. The highly intricate maze of contributing factors provides many potential unanticipated opportunities to design rational therapeutic and preventative strategies.</p></abstract></profileDesc><revisionDesc><change when="1997-08-21">Registration</change><change when="1997">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/4E715B685F8A5777A4925F50E172B66A5E943551/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: tail"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType><istex:document><converted-article version="4.5.2" docsubtype="rev" xml:lang="en"><item-info><jid>YNBDI</jid><aid>90161</aid><ce:pii>S0969-9961(97)90161-3</ce:pii><ce:doi>10.1006/nbdi.1997.0161</ce:doi><ce:copyright type="full-transfer" year="1997">Academic Press</ce:copyright></item-info><head><ce:article-footnote><ce:label>☆</ce:label><ce:note-para>R. N. RosenbergS. B. PrusinerS. DiMauroR. L. Barchi, Eds.</ce:note-para></ce:article-footnote><ce:dochead><ce:textfn>Review</ce:textfn></ce:dochead><ce:title>Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain</ce:title><ce:author-group><ce:author><ce:given-name>Allen D.</ce:given-name><ce:surname>Roses</ce:surname></ce:author><ce:affiliation><ce:textfn>Duke University Medical Center, Durham, North Carolina, 27710-2900</ce:textfn></ce:affiliation></ce:author-group><ce:date-received day="13" month="5" year="1997"></ce:date-received><ce:date-accepted day="21" month="8" year="1997"></ce:date-accepted><ce:abstract><ce:section-title>Abstract</ce:section-title><ce:abstract-sec><ce:simple-para>Age-dependent neurodegeneration in Alzheimer disease (AD) may be viewed as a complex interaction among: (i) susceptibility polymorphisms, (ii) somatic mutations or alterations that occur over extended periods of time, and (iii) environmental interactions. Putative “sporadic” diseases appear to have a much stronger genetic component than had been considered previously. For example, in Alzheimer disease, apolipoprotein E is a major susceptibility locus that accounts for approximately half the heritability. Specific APOE genotypes are associated with different relative risks and age of onset distributions. Disease may be expressed as a confluence of several genetic risk factors, superimposed upon the age-dependent increments of somatic mitochondrial mutations, and environmental determinants such as head injury, stroke, or hypoxia. A matrix involving each of these complex factors may influence the age of onset of AD in a particular individual. With careful clinically based family and epidemiological studies, it is now possible to tease out the relevant genetic contributions from the confluence of other factors leading to complex disease affecting specific sets of neurons. The highly intricate maze of contributing factors provides many potential unanticipated opportunities to design rational therapeutic and preventative strategies.</ce:simple-para></ce:abstract-sec></ce:abstract></head></converted-article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain</title></titleInfo><name type="personal"><namePart type="given">Allen D.</namePart><namePart type="family">Roses</namePart><affiliation>Duke University Medical Center, Durham, North Carolina, 27710-2900</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="Review article"></genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1997</dateIssued><dateValid encoding="w3cdtf">1997-08-21</dateValid><copyrightDate encoding="w3cdtf">1997</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">Age-dependent neurodegeneration in Alzheimer disease (AD) may be viewed as a complex interaction among: (i) susceptibility polymorphisms, (ii) somatic mutations or alterations that occur over extended periods of time, and (iii) environmental interactions. Putative “sporadic” diseases appear to have a much stronger genetic component than had been considered previously. For example, in Alzheimer disease, apolipoprotein E is a major susceptibility locus that accounts for approximately half the heritability. Specific APOE genotypes are associated with different relative risks and age of onset distributions. Disease may be expressed as a confluence of several genetic risk factors, superimposed upon the age-dependent increments of somatic mitochondrial mutations, and environmental determinants such as head injury, stroke, or hypoxia. A matrix involving each of these complex factors may influence the age of onset of AD in a particular individual. With careful clinically based family and epidemiological studies, it is now possible to tease out the relevant genetic contributions from the confluence of other factors leading to complex disease affecting specific sets of neurons. The highly intricate maze of contributing factors provides many potential unanticipated opportunities to design rational therapeutic and preventative strategies.</abstract><note>R. N. RosenbergS. B. PrusinerS. DiMauroR. L. Barchi, Eds.</note><note type="content">Section title: Review</note><relatedItem type="host"><titleInfo><title>Neurobiology of Disease</title></titleInfo><titleInfo type="abbreviated"><title>YNBDI</title></titleInfo><genre type="Journal">journal</genre><originInfo><dateIssued encoding="w3cdtf">1997</dateIssued></originInfo><identifier type="ISSN">0969-9961</identifier><identifier type="PII">S0969-9961(00)X0028-9</identifier><part><date>1997</date><detail type="volume"><number>4</number><caption>vol.</caption></detail><detail type="issue"><number>3–4</number><caption>no.</caption></detail><extent unit="issue pages"><start>135</start><end>311</end></extent><extent unit="pages"><start>170</start><end>185</end></extent></part></relatedItem><identifier type="istex">4E715B685F8A5777A4925F50E172B66A5E943551</identifier><identifier type="DOI">10.1006/nbdi.1997.0161</identifier><identifier type="PII">S0969-9961(97)90161-3</identifier><accessCondition type="use and reproduction" contentType="">© 1997Academic Press</accessCondition><recordInfo><recordContentSource>ELSEVIER</recordContentSource><recordOrigin>Academic Press, ©1997</recordOrigin></recordInfo></mods></metadata><enrichments><istex:catWosTEI uri="https://api.istex.fr/document/4E715B685F8A5777A4925F50E172B66A5E943551/enrichments/catWos"><teiHeader><profileDesc><textClass><classCode scheme="WOS">CLINICAL NEUROLOGY</classCode><classCode scheme="WOS">NEUROSCIENCES</classCode></textClass></profileDesc></teiHeader></istex:catWosTEI></enrichments><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A45 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 002A45 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:4E715B685F8A5777A4925F50E172B66A5E943551
|texte= Apolipoprotein E, a Gene with Complex Biological Interactions in the Aging Brain
}}
| This area was generated with Dilib version V0.6.23. |  |